|
ZNF33B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.32827124036339E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87405646556726E-13 |
| Normal-vs-Stage2 |
6.26076968046618E-12 |
| Normal-vs-Stage3 |
1.47659662275146E-14 |
| Normal-vs-Stage4 |
2.88657986402541E-15 |
| Stage1-vs-Stage2 |
7.187800E-01 |
| Stage1-vs-Stage3 |
2.009600E-01 |
| Stage1-vs-Stage4 |
5.285900E-02 |
| Stage2-vs-Stage3 |
2.011800E-01 |
| Stage2-vs-Stage4 |
4.657600E-02 |
| Stage3-vs-Stage4 |
3.377600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64601665630926E-12 |
| Normal-vs-AfricanAmerican |
8.66020000156453E-09 |
| Normal-vs-Asian |
4.54958293261143E-12 |
| Caucasian-vs-AfricanAmerican |
3.130400E-01 |
| Caucasian-vs-Asian |
3.703400E-01 |
| AfricanAmerican-vs-Asian |
7.674600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.11053396981242E-13 |
| Normal-vs-Female |
1.66489044772788E-12 |
| Male-vs-Female |
4.904000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73894232347038E-12 |
| Normal-vs-Age(41-60Yrs) |
3.50830475781549E-14 |
| Normal-vs-Age(61-80Yrs) |
2.35034214313146E-13 |
| Normal-vs-Age(81-100Yrs) |
5.66819999999746E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.556000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.519000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.575800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.768400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.012200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.538800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.443600E-01 |
| Classical-VS-Follicular |
3.649600E-02 |
| Classical-VS-Other |
4.121800E-01 |
| Classical-VS-Normal |
1.71862524211974E-13 |
| Tall-VS-Follicular |
9.455700E-03 |
| Tall-VS-Other |
3.074400E-01 |
| Tall-VS-Normal |
5.16253706450698E-14 |
| Follicular-VS-Other |
6.044200E-01 |
| Follicular-VS-Normal |
8.44849745718079E-11 |
| Other-VS-Normal |
4.273700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.59126053947512E-13 |
| Normal-vs-N1 |
5.55111512312578E-15 |
| N0-vs-N1 |
8.347700E-02 |
|
|
